Author: Wantavornprasert, K; Noppakun, N; Klaewsongkram, J; Rerknimitr, P
Title: Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination Cord-id: e4l8t81m Document date: 2021_1_1
ID: e4l8t81m
Snippet: A 74-year-old Thai male presented with a rash appearing 25 hours after receiving the first dose of the adenoviral-vectored COVID-19 vaccine, ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca). These lesions abruptly appeared without any accompanying symptoms. The patient's medical history included end stage renal disease, atrial fibrillation, and ischemic stroke. The patient denied taking any new drugs, supplements or food that had not previously consumed prior to this cutaneous eruption.
Document: A 74-year-old Thai male presented with a rash appearing 25 hours after receiving the first dose of the adenoviral-vectored COVID-19 vaccine, ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca). These lesions abruptly appeared without any accompanying symptoms. The patient's medical history included end stage renal disease, atrial fibrillation, and ischemic stroke. The patient denied taking any new drugs, supplements or food that had not previously consumed prior to this cutaneous eruption.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date